Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-16
2010-02-23
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S112000
Reexamination Certificate
active
07666878
ABSTRACT:
There are provided according to the invention compounds of formula (I),in free or salt form, wherein R1, R2, R3, R 4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
REFERENCES:
patent: 5212195 (1993-05-01), Clark et al.
patent: 6248753 (2001-06-01), Chen
patent: 2008/0287416 (2008-11-01), Sandham et al.
patent: 2008/0312229 (2008-12-01), Sandham et al.
patent: 2008/0312230 (2008-12-01), Sandham
patent: 1 424 325 (2004-06-01), None
patent: 1 505 061 (2005-02-01), None
patent: 9507910 (1995-03-01), None
patent: WO 95/07910 (1995-03-01), None
patent: WO 95/33748 (1995-12-01), None
patent: WO 02/34747 (2002-05-01), None
patent: WO 03/066047 (2003-08-01), None
patent: WO 2004/007451 (2004-01-01), None
patent: WO 2005/040112 (2005-05-01), None
patent: WO 2005/121141 (2005-12-01), None
Andrew Brodrick et al, “1H-Pyrrolo[2,3-b]pyridines. Part III. A Novel Synthetic Route From 1-Substituted 2-Aminopyrroles” J. Organic Chemistry 19:1910-1913, 1975.
Anthony Verbiscar, “Synthesis of 1-p-Chlorobenzy1-7-azaindole-3-alpha-piperidylmethanol as a Potential Antimalarial Agent” J. Medicinal Chemistry 15(2):149-152, 1975.
Adberrahim Mouaddib et al., “Synthesis of Indolo[3,2-c]quinoline and Pyrido[3',2':4,5][3,2-c]quinoline Derivatives” Synthesis 4:549-556, 2000.
Adberrahim Mouaddib et al., “Synthesis of Benzo[5'6']cyclohepta[4,5] pyrrolo[2,3-beta]pyridin-12-one” Tetrahedron Letters 40:5853-5854, 1999.
C. Nicholas Hodge et al., “Corticotropin-Releasing Hormone Receptor Antagontists: Framework Design and Synthesis Guided . . . ” J. Med. Chem. 42:819-832, 1999.
Yakhontov et al., Khimiya Geterotsiklicheskikh Soedinenii 1:141-144, 1967.
Yakhonotov et al., Biol. Aktivn. Soedin, Akad. Nauk SSSR pp. 83-90, 1965.
Bala Kamlesh Jagdis
Brown Lyndon Nigel
Cox Brian
Leblanc Catherine
Sandham David Andrew
Kathardekar Vinit
Milstead Mark
Novartis AG
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Pyrrolopyridine derivatives and their use as Crth2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyridine derivatives and their use as Crth2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyridine derivatives and their use as Crth2 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4190184